See more : Alqemam for Computer Systems Co. (9558.SR) Income Statement Analysis – Financial Results
Complete financial analysis of Clever Leaves Holdings Inc. (CLVR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Clever Leaves Holdings Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Expensify, Inc. (EXFY) Income Statement Analysis – Financial Results
- Nozawa Corporation (5237.T) Income Statement Analysis – Financial Results
- PAO NOVATEK (NVTK.IL) Income Statement Analysis – Financial Results
- GDH Supertime Group Company Limited (001338.SZ) Income Statement Analysis – Financial Results
- Kerry Express (Thailand) Public Company Limited (KEX.BK) Income Statement Analysis – Financial Results
Clever Leaves Holdings Inc. (CLVR)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.cleverleaves.com
About Clever Leaves Holdings Inc.
Clever Leaves Holdings Inc. operates as a cannabis company. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. The company was founded in 2017 and is based in Boca Raton, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 17.42M | 17.80M | 15.37M | 12.12M | 7.83M | 0.00 |
| Cost of Revenue | 10.86M | 13.47M | 8.57M | 4.70M | 4.73M | 99.00K |
| Gross Profit | 6.56M | 4.33M | 6.81M | 7.41M | 3.10M | -99.00K |
| Gross Profit Ratio | 37.64% | 24.33% | 44.29% | 61.18% | 39.60% | 0.00% |
| Research & Development | 1.14M | 1.72M | 1.55M | 1.01M | 0.00 | 0.00 |
| General & Administrative | 17.99M | 27.82M | 38.40M | 29.83M | 34.98M | 4.75M |
| Selling & Marketing | 2.04M | 1.90M | 3.80M | 2.58M | 3.18M | 417.00K |
| SG&A | 20.03M | 29.71M | 42.19M | 32.41M | 38.16M | 5.31M |
| Other Expenses | 0.00 | 2.06M | 1.77M | 1.85M | 1.48M | 0.00 |
| Operating Expenses | 21.17M | 33.49M | 45.51M | 34.26M | 39.64M | 5.31M |
| Cost & Expenses | 33.01M | 46.96M | 54.07M | 38.96M | 44.37M | 5.41M |
| Interest Income | 0.00 | 2.70M | 6.82M | 4.46M | 2.68M | 390.00K |
| Interest Expense | 46.00K | 2.70M | 6.82M | 4.46M | 2.68M | 0.00 |
| Depreciation & Amortization | 2.85M | 3.67M | 3.51M | 3.59M | 1.48M | 99.00K |
| EBITDA | -16.84M | -35.80M | -35.19M | -23.26M | -41.72M | -5.31M |
| EBITDA Ratio | -96.66% | -144.33% | -225.63% | -203.91% | -454.35% | 0.00% |
| Operating Income | -15.59M | -29.16M | -38.70M | -26.85M | -36.54M | -5.41M |
| Operating Income Ratio | -89.53% | -163.82% | -251.72% | -221.56% | -466.43% | 0.00% |
| Total Other Income/Expenses | -4.14M | -15.00M | -5.98M | 951.00K | -9.34M | 13.15M |
| Income Before Tax | -19.73M | -72.46M | -44.68M | -36.68M | -45.88M | 7.74M |
| Income Before Tax Ratio | -113.27% | -407.05% | -290.63% | -302.67% | -585.70% | 0.00% |
| Income Tax Expense | 68.00K | -6.35M | 950.00K | 4.74M | 2.25M | -126.00K |
| Net Income | -17.90M | -66.10M | -45.63M | -41.41M | -48.13M | 7.36M |
| Net Income Ratio | -102.77% | -371.35% | -296.81% | -341.78% | -614.37% | 0.00% |
| EPS | -11.42 | -51.65 | -53.29 | -49.93 | -184.77 | 0.00 |
| EPS Diluted | -11.42 | -51.65 | -53.29 | -49.93 | -184.77 | 0.00 |
| Weighted Avg Shares Out | 1.57M | 1.28M | 856.34K | 829.43K | 260.49K | 0.00 |
| Weighted Avg Shares Out (Dil) | 1.57M | 1.28M | 856.34K | 829.43K | 260.49K | 0.00 |
5 Short Squeeze Candidates To Watch: Aterian And Newegg Remain In Top Two Positions, Cannabis Company Joins List Week Of 4/20
Best Marijuana Stocks To Buy Now? 3 Cannabis Stocks For Your List In April
Best Marijuana Stocks For Your Watch List For April 2022
3 Trending Penny Stocks to Watch in April 2022
Why Is Clever Leaves (CLVR) Stock Up Today?
3 Penny Stocks to Watch With Unemployment Rate Down
5 Penny Stocks To Buy According To Big Money Options Bets Right Now
Why Is Clever Leaves (CLVR) Stock Up Today?
Why Clever Leaves Stock Is Trading Higher And What Investors Need To Know
Clever Leaves Holdings, Inc. (CLVR) CEO Kyle Detwiler on Q4 2021 Results - Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports